Catalyst Pharmaceuticals Inc (CPRX)
21.62
+0.02
(+0.09%)
USD |
NASDAQ |
Dec 24, 16:00
Catalyst Pharmaceuticals Free Cash Flow: 221.79M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics Inc | 142.60M |
| Vertex Pharmaceuticals Inc | -1.352B |
| Sarepta Therapeutics Inc | -480.40M |
| ADMA Biologics Inc | 78.82M |
| Regenxbio Inc | -184.74M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 72.87M |
| Cash from Investing (Quarterly) | -0.259M |
| Cash from Financing (Quarterly) | -5.974M |
| Free Cash Flow Per Share (Quarterly) | 0.579 |
| Free Cash Flow to Equity (Quarterly) | 72.61M |
| Free Cash Flow to Firm (Quarterly) | 72.61M |
| Free Cash Flow Yield | 8.42% |